Delivery Order SPE2DE24D0013-SPE2D626F82E6
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $3,400 under contract XPRS4PLEX-10 by the Defense Logistics Agency Medical Supply Chain, with an ultimate completion date of December 4, 2025. This firm fixed-price delivery order, awarded on November 26, 2025, utilizes no set-aside designation and will be performed at the contractor's Sunnyvale facility. The delivery order is structured under the Defense Logistics Agency's medical supply chain...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $1,190.28 by the Defense Logistics Agency Medical Supply Chain with an ultimate completion date of January 21, 2026. This firm fixed-price delivery order, issued on January 6, 2026, carries no set-aside designation and represents performance at Cepheid's Sunnyvale, California facility. The award is structured as a delivery order under a larger contracting vehicle, consistent with the Defense...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $2,304.20 by the Defense Logistics Agency Medical Supply Chain, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, designated XPRSMVP-10, represents a continuation of Cepheid's ongoing role as a primary federal supplier of molecular diagnostic solutions. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning in the...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a firm fixed-price delivery order valued at $1,840 with an ultimate completion date of December 23, 2025. This delivery order, designated XPRSTREPA-10, was issued on December 16, 2025, by the Defense Logistics Agency Medical Supply Chain, a component of the Department of Defense. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as an established federal supplier of molecular...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $3,400 under contract XPRS4PLEX-10 by the Defense Logistics Agency's Medical Supply Chain on December 3, 2025, with an ultimate completion date of December 10, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a procurement of diagnostic testing supplies from Cepheid, a leading manufacturer of molecular diagnostic systems and reagents specializing in...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $33,200.20 by the Defense Logistics Agency Medical Supply Chain on November 25, 2025, with an ultimate completion date of December 3, 2025. This delivery order, designated XPRSMVP-10, carries no set-aside designation and will be performed at Cepheid's Sunnyvale facility. As a leading manufacturer of advanced molecular diagnostic systems and reagents, Cepheid supplies the Defense...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $12,240 firm fixed-price delivery order (Contract No. 4569923617, XPRS4PLEX-10) by the Defense Logistics Agency's Medical Supply Chain on November 4, 2025, with an ultimate completion date of November 12, 2025. The delivery order was issued without a set-aside designation and is performed at Cepheid's Sunnyvale facility. As a leading manufacturer of advanced molecular diagnostic systems and reagents, Cepheid supplies the...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,720 by the Defense Logistics Agency Medical Supply Chain on December 17, 2025, with an ultimate completion date of December 24, 2025. This delivery order, designated XPRS4PLEX-10, is issued under an Indefinite Delivery Contract framework and carries no set-aside designation. The contract calls for the delivery of diagnostic reagents and test kits designed for Cepheid's GeneXpert...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. As a leading federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F82E6Delivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $6,800 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 13, 2026. The delivery order, designated XPRS4PLEX-10, was issued under an existing Indefinite Delivery Contract and carries no set-aside designation. As a leading manufacturer of molecular diagnostic systems and reagents, Cepheid supplied diagnostic testing supplies, specifically XPRS4PLEX-10 cartridges designed for the GeneXpert diagnostic platform to detect multiple respiratory pathogens. The company's placement in Sunnyvale, California serves as the performance location for this order. This delivery order represents a continuation of Cepheid's extensive relationship with the Defense Logistics Agency Medical Supply Chain, which has issued numerous orders for diagnostic testing supplies and reagents to support federal healthcare operations. The contract reflects Cepheid's established role as a primary federal supplier of molecular diagnostic solutions across multiple Department of Defense and civilian healthcare agencies, including the Department of Veterans Affairs, Indian Health Service, and Defense Health Agency. The firm fixed-price structure and rapid completion timeline demonstrate the expedited procurement nature of this supply order for critical diagnostic capabilities within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 1/5/26 |